INTS — INTENSITY THERAPEUTICS, INC.

—
Nasdaq · Health Care · Biotechnology · CIK 1567264 ·
Last close
$2.67
Market Cap
$8.81M
52W High
$15.00
52W Low
$2.59
ADV30
19,611
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 0 — -3,084,000 -3,007,000 11,521,000 9,529,000 2,307,000
Mar 2026 0 — -2,526,000 -2,434,000 12,291,000 10,245,000 2,312,000
Dec 2025 0 — -3,140,000 -3,051,000 14,101,000 11,921,000 2,225,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-8,954,000
Investing CF
$0
Financing CF
$16,267,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-6.93
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-83,830,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-11,483,000
Pretax Income TTM
$-11,163,000
Interest Exp TTM
—
Analysts
6

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -11,972,000 -11,606,000 14,101,000 2,225,000 11,876,000 -9,233,000
Dec 2024 0 -16,585,000 -16,268,000 4,783,000 1,865,000 2,918,000 -15,220,000
Dec 2023 0 -8,319,000 -10,538,000 17,295,000 4,133,000 13,162,000 -7,205,000
Dec 2022 0 -7,550,000 -7,582,000 1,757,000 16,855,000 -15,098,000 -5,477,000

TTM Snapshot

Revenues TTM
$319,000
NetIncome TTM
$-11,163,000
OpCashFlow TTM
—
Assets (Latest)
$11,521,000
Forward EPS
$-1.99

Peers — same industry

TickerNameMarket CapLastDaily %
INAB IN8BIO, INC. $8.86M $0.82 —
TCRX TScan Therapeutics, Inc. $9.59M $0.15 —
BCLI BRAINSTORM CELL THERAPEUTICS INC. $9.72M $0.88 —
CUBT Curative Biotechnology Inc $7.56M $0.85 —
ALGS Aligos Therapeutics, Inc. $7.40M $1.36 —

News headlines (Yahoo Finance, 1h cache)

Intensity (INTS) Q3 2026 Earnings Call Transcript
2026-11-05 22:28 · Yahoo
Intensity Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-05 12:45 · Yahoo
Intensity Therapeutics to Announce Third Quarter 2026 Financial Results on November 5, 2026
2026-10-30 12:00 · Yahoo
Intensity Therapeutics, Inc. to Present INVINCIBLE-4 Neoadjuvant Triple-Negative Breast Cancer Study Data for the First Seven (7) Patients After INT230-6 Treatment (Cohort A) in an ePoster Presentatio
2026-10-23 12:00 · Yahoo
Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-08 12:00 · Yahoo
Intensity Therapeutics (INTS) Q2 2026 Earnings Call Transcript
2026-08-12 01:57 · Yahoo
Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026
2026-08-04 12:00 · Yahoo
Intensity Therapeutics Provides Mid-Year Update Highlighting Late-Stage Development Programs and Strategic Partnering Opportunities for INT230-6
2026-07-01 12:00 · Yahoo
Intensity Therapeutics Inc. (INTS) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
2026-05-01 13:55 · Yahoo
Intensity Therapeutics Recognized with GHP Magazine's 2026 Healthcare & Pharmaceutical Award
2026-05-14 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.